Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Myeloma

Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma

Abstract

Molecular and genetic events associated with the transition from monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma (MM) are still poorly characterized. We investigated serial bone marrow specimens from 11 patients with MGUS who eventually progressed to MM (MM post-MGUS) by interphase fluorescence in situ hybridization for immunoglobulin heavy-chain gene (IgH) translocations and chromosome 13q deletions (del(13q)). In nine patients, IgH translocations were present both in MGUS and MM post-MGUS plasma cells, including three t(11;14)(q13;q32) and one t(4;14)(p16;q32), which was observed already 92 months prior to MM. Similarly, all five MM patients with del(13q) had this aberration already at the MGUS stage. Two patients without IgH translocation and del(13q) had chromosomal gains suggesting hyperdiploidy, but IgH translocations and/or del(13q) did not emerge at MM post-MGUS. IgH translocations and del(13q) are early genetic events in monoclonal gammopathies, suggesting that additional events are required for the transition from stable MGUS to progressive MM.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 2002; 346: 564–569.

    Article  PubMed  Google Scholar 

  2. Seidl S, Kaufmann H, Drach J . New insights into the pathophysiology of multiple myeloma. Lancet Oncol 2003; 4: 557–564.

    Article  CAS  PubMed  Google Scholar 

  3. Fonseca R, Barlogie B, Bataille R, Bastard C, Bergsagel PL, Chesi M et al. Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res 2004; 64: 1546–1558.

    Article  CAS  PubMed  Google Scholar 

  4. Hallek M, Bergsagel PL, Anderson KC . Multiple myeloma: increasing evidence for a multistep transformation process. Blood 1998; 91: 3–21.

    CAS  PubMed  Google Scholar 

  5. Kuehl WM, Bergsagel PL . Multiple myeloma: evolving genetic events and host interactions. Nat Rev Cancer 2002; 2: 175–187.

    Article  CAS  PubMed  Google Scholar 

  6. Fonseca R, Bailey RJ, Ahmann GJ, Rajkumar V, Hoyer JD, Lust LA et al. Genomic abnormalities in monoclonal gammopathy of undetermined significance. Blood 2002; 100: 1417–1424.

    CAS  PubMed  Google Scholar 

  7. Avet-Loiseau H, Facon T, Daviet A, Godon C, Rapp MJ, Harousseau JL et al. 14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Cancer Res 1999; 59: 4546–4550.

    CAS  PubMed  Google Scholar 

  8. Königsberg R, Ackermann J, Kaufmann H, Zojer N, Urbauer E, Krömer E et al. Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance. Leukemia 2000; 14: 1975–1979.

    Article  PubMed  Google Scholar 

  9. Avet-Loiseau H, Li JY, Morineau N, Facon T, Brigaudeau C, Harousseau JL et al. Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Blood 1999; 94: 2583–2589.

    CAS  PubMed  Google Scholar 

  10. Bernasconi P, Cavigliano PM, Boni M, Astori C, Calatroni S, Giardini I et al. Long-term follow up with conventional cytogenetics and band 13q14 interphase/metaphase in situ hybridization monitoring in monoclonal gammopathies of undetermined significance. Br J Haematol 2002; 118: 545–549.

    Article  PubMed  Google Scholar 

  11. International-Myeloma-Working-Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma, and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003; 121: 749–757.

  12. Fonseca R, Debes-Marun CS, Picken EB, Dewald GW, Bryant SC, Winkler JM et al. The recurrent IgH translocations are highly associated with nonhyperdiploid variant of multiple myeloma. Blood 2003; 102: 2562–2567.

    Article  CAS  PubMed  Google Scholar 

  13. Kaufmann H, Ackermann J, Nosslinger T, Kromer E, Zojer N, Schreiber S et al. Absence of clonal chromosomal relationship between concomitant B-CLL and multiple myeloma – a report on two cases. Ann Hematol 2001; 80: 474–478.

    Article  CAS  PubMed  Google Scholar 

  14. Zojer N, Konigsberg R, Ackermann J, Fritz E, Dallinger S, Kromer E et al. Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization. Blood 2000; 95: 1925–1930.

    CAS  PubMed  Google Scholar 

  15. Moreau P, Facon T, Leleu X, Morineau N, Huyghe P, Harousseau JL et al. Intergroupe Francophone du Myelome. Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy. Blood 2002; 100: 1579–1583.

    Article  CAS  PubMed  Google Scholar 

  16. Fonseca R, Blood E, Rue M, Harrington D, Oken MM, Kyle RA et al. Clinical and biological implications of recurrent genomic aberrations in myeloma. Blood 2003; 101: 4569–4575.

    Article  CAS  PubMed  Google Scholar 

  17. Chang H, Sloan S, Li D, Zhuang L, Yi QL, Chen CI et al. The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplantation. Br J Haematol 2004; 125: 64–68.

    Article  PubMed  Google Scholar 

  18. Drach J, Angerler J, Schuster J, Rothermundt C, Thalhammer R, Haas OA et al. Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance. Blood 1995; 86: 3915–3921.

    CAS  PubMed  Google Scholar 

  19. Zandecki M, Lai JL, Genevieve F, Bernardi F, Volle-Remy H, Blanchet O et al. Several cytogenetic subclones may be identified within plasma cells from patients with monoclonal gammopathy of undetermined significance, both at diagnosis and during the indolent course of this condition. Blood 1997; 90: 3682–3690.

    CAS  PubMed  Google Scholar 

  20. Rasillo A, Tabernero MD, Sanchez ML, Perez de Andres M, Martin Ayuso M, Hernandez J et al. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia. Cancer 2003; 97: 601–609.

    Article  PubMed  Google Scholar 

  21. Seidl S, Ackermann J, Kaufmann H, Keck A, Nosslinger T, Zielinski CC et al. DNA-methylation analysis identifies the E-cadherin gene as a potential marker of disease progression in patients with monoclonal gammopathies. Cancer 2004; 100: 2598–2606.

    Article  CAS  PubMed  Google Scholar 

  22. Davies FE, Dring AM, Li C, Rawstron AC, Shammas MA, O’Connor SM et al. Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis. Blood 2003; 102: 4504–4511.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported in part by grants from the Austrian National Bank (Jubiläumsfonds Project # 7730), CLEXO (Center of excellence in clinical and experimental oncology) and UNRUHE Privatstiftung.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J Drach.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaufmann, H., Ackermann, J., Baldia, C. et al. Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma. Leukemia 18, 1879–1882 (2004). https://doi.org/10.1038/sj.leu.2403518

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403518

Keywords

This article is cited by

Search

Quick links